Huntington's disease is one of nine neurodegenerative disorders caused by expansion of CAG repeats encoding polyglutamine in their respective, otherwise apparently unrelated proteins.
ABSTRACT (250)
Huntington's disease is one of nine neurodegenerative disorders caused by expansion of CAG repeats encoding polyglutamine in their respective, otherwise apparently unrelated proteins.
Despite these proteins having widespread and overlapping expression patterns in the brain, a specific and unique subset of neurons exhibits particular vulnerability in each disease. It has been hypothesized that perturbation of normal protein function contributes to the specificity of neuronal vulnerability, however the normal biological functions of many of these proteins including the HD gene product, Huntingtin (Htt), are unclear.
To explore the roles of Htt, we have used antisense morpholino oligonucleotides to observe the effects of Htt deficiency in early zebrafish development. Knockdown of Htt expression resulted in a variety of developmental defects. Most notably, Htt-deficient zebrafish had hypochromic blood due to decreased haemoglobin production, despite the presence of iron within blood cells.
Furthermore, transferrin receptor 1 transcripts were increased, suggesting cellular iron starvation.
Provision of iron to the cytoplasm in a bio-available form restored haemoglobin production in Httdeficient embryos. Since erythroid cells acquire iron via receptor-mediated endocytosis of transferrin, these results suggest a role for Htt in making endocytosed iron accessible for cellular utilization.
Iron is required for oxidative energy production, and defects in iron homeostasis and energy metabolism are features of HD pathogenesis that are most pronounced in the major region of neurodegeneration. It is therefore plausible that perturbation of Htt's normal role in the iron pathway (by polyglutamine tract expansion) contributes to HD pathology, and particularly to its neuronal specificity.
INTRODUCTION
Huntington's disease (HD) is a dominant, progressive neurodegenerative disorder characterized by cognitive deficits, choreic involuntary movements, mood disturbances and weight loss despite adequate dietary intake. HD is caused by the expansion of an unstable CAG trinucleotide repeat within the coding region of the HD gene (also known as IT15), resulting in an expanded polyglutamine tract in the encoded protein, Huntingtin (Htt). HD is one of nine diseases caused by expansion of polyglutamine tracts in different proteins, the others being spinobulbar muscular atrophy (SBMA), dentatorubral pallidoluysian atrophy (DRPLA), and spinocerebellar ataxias (SCAs) 1, 2, 3, 6, 7 and 17. Features common to these disorders include delayed onset neurodegeneration and dominant inheritance. Furthermore, the age of onset of clinical symptoms decreases with increasing repeat copy number. Largely due to the dominant inheritance of these diseases, it is generally believed that the expanded polyglutamine tract confers a toxic gain-offunction upon each affected protein. This notion has been supported by findings that expression of disease-length polyglutamine tracts within truncated Htt fragments or in isolation cause cellular dysfunction and/or cell death in a variety of model systems, including mouse (1), nematode (2), zebrafish (3, 4) , Drosophila (5, 6) , Saccharomyces (7) , and cultured neurons (8) .
However, in the human polyglutamine diseases, despite the proteins having widespread and overlapping patterns of endogenous expression, only a subset of neurons is most prone to degeneration. Furthermore, a different subset of neurons degenerates from one disease to the next, as reflected in variable clinical features. It is likely that the unique specificities of neuronal vulnerability in each of these diseases are mediated somehow by the different protein contexts in which the polyglutamine tracts reside. There is increasing evidence that unique attributes of the affected proteins, outside of the polyglutamine tract, are critical for neurodegeneration. For example, in SCA1, neurodegeneration is dependent upon the phosphorylation of a serine residue within the mutant protein, ataxin-1 (9) . In SBMA, nuclear translocation of the mutant androgen receptor upon binding of its ligand, testosterone, is required for neurodegeneration (10) . In SCA6, the polyglutamine expansion perturbs the normal function of the calcium channel subunit in which it resides (11, 12) leading to symptoms that resemble those of other channelopathies unrelated to polyglutamine (13) . Currently, the normal functions of many of the proteins affected in polyglutamine diseases (including Htt) are unclear. Further understanding of their normal functions and the biological processes in which they are involved is likely to provide further insight into the molecular pathway(s) underlying pathology in these diseases.
In HD, although the expanded Htt allele (like wildtype Htt) is expressed throughout the brain, a hierarchy of neuronal vulnerability to degeneration exists. Characteristically, HD neuropathology is most striking in the striatum, where medium spiny γ-aminobutyric acid (GABA)-utilizing neurons that project to the substantia nigra and globus pallidus are gradually, and selectively, lost (14, 15) . Neurons in the deeper layers of the cerebral cortex are also vulnerable, and pathology has been observed to a lesser extent in other regions of the brain, whilst some areas, also expressing the mutant protein, seem relatively unaffected. What determines this hierarchy of sensitivity to expanded mutant Htt has not yet been established.
In the HD striatum, decreased glucose metabolism is observed prior to the bulk of cell loss (and clinical symptoms) (16) (17) (18) , supporting the notion that cellular dysfunction precedes cell death.
Signs of decreased oxidative respiration are evident in this region, including a reduction in activities of the citrate acid cycle enzyme, aconitase (19) , and mitochondrial respiratory complexes II-IV (20, 21) . Consistent with these findings, decreased striatal oxygen consumption (22) and increased lactate concentrations in the basal ganglia and occipital cortex have also been reported (23, 24) .
Other abnormalities observed in the HD striatum include increased excitotoxicity (25) , accumulation of iron (26) (27) (28) (29) and markers of oxidative stress (30) . The underlying mechanism by which expanded mutant Htt triggers these effects and why the striatum is most vulnerable is unknown.
Htt is a relatively large protein (~350 kDa) that has a widespread distribution throughout the human body suggesting that it plays a ubiquitous role that is not limited to neurons. Within the cell Htt is mostly found in the cytoplasm where it is concentrated in the perinuclear region (31, 32) , although it has also been detected in dendrites and nerve endings (33, 34) and within the nucleus (35) (36) (37) (38) . Htt associates with a variety of cellular structures and organelles including the plasma membrane, clathrin-coated and non-coated vesicles, endosomes, endoplasmic reticulum, Golgi complex, mitochondria, and microtubules (31, 33, (39) (40) (41) (42) (43) (44) . This wide variety of associations and lack of distinct compartmentalisation has not made the role of Htt immediately clear.
Since the identification of the HD gene fourteen years ago (45) , Htt has been implicated in a large variety of cellular processes including apoptosis, endocytosis, vesicle trafficking, transcriptional regulation, and dendrite formation (see for recent reviews, refs (46, 47) ). Studies in mouse have revealed a dose-dependent response to Htt depletion. Whilst a single active allele of the mouse orthologues (Hdh) is sufficient for healthy development (48) (49) (50) , a hypomorphic Hdh allele resulting in a reduction of Htt levels to one third of wildtype levels produces severe cranial and brain abnormalities leading to lethality around the time of birth (51) . Homozygous inactivation of the Hdh gene leads to early embryonic lethality (48-50) associated with increased apoptosis (48) and disrupted transport of maternal nutrients into the fetus (52) . In a conditional mouse model, postnatal Hdh inactivation in the forebrain and testes results in cellular dysfunction and cell death in those regions (53) . These findings indicate that Htt plays a vital role and is critical for cellular viability.
Past investigations of Htt function in vivo have been somewhat limited by the lack of a viable mouse model of Htt deficiency. Here a novel approach is taken by using antisense methodology (morpholino oligonucleotides; MOs) to transiently 'knock down' hd gene function in early zebrafish development. A major advantage of using the zebrafish/MO system is that zebrafish produce optically transparent embryos that develop externally, allowing the morphological effects of Htt knockdown to be observed in live embryos, non-invasively, under the microscope.
Furthermore, the MO method of gene knockdown enables the extent of inhibition to be adjusted by modifying the dose of MOs administered, thus allowing the effects of partial Htt depletion to be investigated. This study investigates the effects of Htt-deficiency in zebrafish, in the hope that characterisation of the resulting phenotypes might provide further insight into the normal biological role of Htt, and provide some insight into whether perturbation of this normal function is capable of contributing to the specificity of neuronal vulnerability seen in HD. Our findings reveal a requirement for Htt in cellular iron utilization.
RESULTS

Expression pattern of the hd gene in early zebrafish development
The Htt protein encoded by the zebrafish orthologue of the HD gene (hd) has been detected at high levels in late embryonic development (54) . To visualize the expression pattern of the hd gene in early zebrafish development, whole-mount in situ hybridization was performed on embryos of various stages from 1-cell to 48 hours post fertilization (hpf; Fig. 1A-F ). Zebrafish hd transcript was detected at the 1-cell stage, prior to the onset of zygotic expression (which starts between 2.3 and 5.3 hpf (55)) and is therefore maternally deposited. Distribution of the hd transcripts was uniform throughout the embryo during gastrulation (Fig. 1B) , but as development progressed, expression decreased in non-neural tissues and was strongest in the head. This pattern of zebrafish hd mRNA distribution is consistent with the early uniformity (49, 52, 56) and subsequent downregulation in non-neuronal tissues (56) of Hdh mRNA expression in rodent development. It is also similar to that of many 'housekeeping' genes (57) , normally associated with the maintenance of a basal cellular function (58) .
Knockdown of zebrafish Htt function
Given the early expression of hd in zebrafish, and that Hdh knockout mice die during embryonic development (48) (49) (50) , it was hypothesized that depleting, rather than eliminating, Htt protein in zebrafish embryos using antisense translation inhibitors (morpholino oligonucleotides;
MOs) would have a detrimental, yet diminished, effect on zebrafish development and produce phenotypes that would provide insight into the normal role of Htt. Two non-overlapping MOs (hdMO1 and hdMO2) were designed to specifically target the hd translation initiation codon and 5' UTR. As negative controls, either a standard negative control morpholino (cMO), or a mispair . These results showed that both hdMO1 and hdMO2 were each able to bind their hd-specific target sequence and prevent translation.
In addition, antibodies raised against the N-terminus of zebrafish Htt were used to confirm a reduction in endogenous Htt levels. Embryos were injected at the 1-cell stage with cMO or hdMO1 (21 ng) and extracts were prepared from these and wildtype uninjected embryos after 48 hpf.
Western blot analysis with the antisera showed that Htt expression was greatly reduced in embryos injected with hdMO1 compared to uninjected or cMO-injected embryos (Fig. 2E ).
Developmental consequences of Htt depletion in zebrafish
To investigate the normal role of Htt in development, hdMO1 or hdMO2 (21 ng) was injected into 1-cell embryos and examined during early development. The same spectrum of phenotypes was produced using either hdMO1 or hdMO2, indicating specificity of Htt knockdown.
Early in development, throughout gastrulation, somitogenesis and early neurulation (formation of the neural plate, neural keel and notochord), Htt-deficient embryos appeared similar to cMOinjected embryos. By 18 hpf, Htt-deficient embryos often exhibited slight growth delay. Brain necrosis was seen at this time, and persisted at 24 hpf when it was also evident that the brain ventricles had not enlarged as they had in control embryos (Fig. 2F-H) . At 26 hpf (Fig. 2I-K ) the yolk extension (YE) was notably thinner than in control embryos and had disappeared in the majority of hdMO-injected embryos by 48 hpf ( Fig. 2L-P) . At this stage, Htt-deficient embryos were shorter, and had delayed or paler pigmentation of melanophores, small head and eyes, and pale or colorless blood. In more severely affected embryos, the tail was often twisted and/or truncated ( Fig. 2N and P) . By 96 hpf, the melanophores had developed in color, but their patterning along the length of the body was obviously disrupted (Fig. 2Q-U) . The body was also thinner than control embryos, and appeared necrotic. At this stage the hdMO-injected embryos appeared to have poorly formed jaw and branchial arch structures and the swim bladder had not inflated as it had in cMOinjected embryos by this time. These phenotypes were often accompanied by pericardial edema (Fig. 2R ).
Since Htt deficiency had such a global effect on zebrafish development it was difficult to ascertain which aspects of the morphant phenotype were primary effects of Htt depletion and which were secondary consequences. To address this issue, a lower morpholino dose (8.5 ng/embryo) was Htt-deficient and wildtype embryos ( Fig. 3C and D) . Rather, the blood cells were lacking red pigment ( Fig. 3B ). All further morpholino experiments were performed using this lower dose (8.5
ng/embryo).
The various characteristics of the Htt morphant phenotype were compared to those of zebrafish genetic mutant phenotypes listed on the Zebrafish Information Network database (www.zfin.org). Aspects of the Htt morphant phenotype such as brain (or CNS) necrosis, pericardial edema, small head and eyes, and thin YE were found to occur frequently amongst zebrafish genetic mutant strains with defects in housekeeping genes, and thus did not reveal any obvious hints as to Htt function. The blood hypochromia, however, is observed in mutants with deficits in haemoglobin (Hb) production (59, 60) and is often caused by a disruption in iron metabolism (61) (62) (63) . This phenotype of Htt morphant embryos was intriguing since wildtype Htt has been previously implicated in iron homeostasis and haematopoiesis in cultured cells (64, 65) , and also in the transport of nutrients such as iron across the visceral endoderm from maternal to embryonic tissues in the mouse fetus (52) . Furthermore, expression of β globin (embryonic βH-1
and adult β) has been shown to be increased in haematopoietic cells derived from an Hdh knockout mouse model (64) suggesting that the hypochromia phenotype in Htt-deficient zebrafish was unlikely to be caused by a defect in globin expression. Htt-deficient zebrafish also showed no evidence of porphyric blood photosensitivity or blood autofluorescence characteristic of zebrafish with mutations affecting enzymes downstream of the initial Alas2-catalyzed step in mitochondrial haem biosynthesis (66, 67) .
Expression of hd mRNA in zebrafish erythroid tissue
Zebrafish embryos hybridised with hd mRNA probe were examined to see if hd is normally expressed in erythroid cells that manufacture Hb, as this would be consistent with Htt having a role in these cells. Zebrafish haematopoiesis occurs in two successive waves, 'primitive' and 'definitive'
as it does in other vertebrates (68) . The primitive wave of haematopoiesis produces predominantly erythroid cells that begin to circulate at 24-26 hpf. It is this period of zebrafish haematopoiesis that was examined in the current study. The site of primitive zebrafish erythropoiesis is the intermediate cell mass (ICM), which is analogous to extraembryonic yolk sac blood islands of mammals and birds.
hd mRNA was detected ubiquitously throughout the tail, including the ICM at 22 hpf, prior to the onset of circulation of erythroid cells (Fig. 3F ). Expression is shown in comparison to notch2 expression, which is detected in somites but is notably absent in the ICM (Fig. 3E ). At 36 hpf hd mRNA was also detected in the posterior ICM ( Fig 3G) more strongly than the basal expression in the rest of the tail. By this time the majority of circulating cells are of the erythroid lineage, although haematopoietic activity in the ICM tissue is not exclusively erythroid (68) . Expression of hd mRNA in the ICM is consistent with Hdh gene products having also been detected in a range of mouse haematopoietic tissues (64) . 
Transient knockdown of haemoglobin production
Iron staining in whole embryos and isolated blood cells
In the zebrafish embryo, iron is absorbed from maternally derived stores in the yolk (63) and erythroid cells endocytose iron from the plasma as transferrin (Tf) via the Tf receptor (TfR) (61) . To investigate the possibility that the decrease in Hb levels could be due to a disruption in iron transport, DAB-enhanced Prussian blue staining was used to detect the presence of ferric iron in morphant and control embryos ( (52), and see Materials and methods) in order to assess any differences in iron distribution.
At 36 hpf, ferric iron was detected throughout the animal (non-yolk) part of Htt-deficient embryos at a level at least the same, and in many cases higher, than in wildtype embryos ( Fig. 4A and B). In wildtype embryos ferric iron was also present in the peripheral layer that surrounds the yolk sac, presumably representing the yolk iron stores (100%, n = 52/52; Fig. 4A , arrow). Embryos injected with hdMO1 frequently lacked staining in this region (Fig. 4B, arrow) , with only 54% staining positively in the yolk syncytial layer (n = 32/59). All hdMO1-injected embryos that lacked iron staining in the yolk also had a thin yolk extension. These results suggested that more iron was being absorbed from the maternally derived yolk stores in Htt morphant embryos, and indicated that hypochromia was not due to impaired uptake of iron from the yolk.
Blood cells visible in the ventral tail region of morphant embryos (predominantly of the erythroid lineage at this stage) stained positively for ferric iron suggesting that iron was able to enter the Htt-deficient blood cells (Fig. 4 C-F) . To examine blood iron staining more closely, embryos were injected with hdMO1 or mcMO1 (mispair control MO), and blood cells were extracted at 33 hpf, for DAB-enhanced Prussian blue staining. The Prussian blue staining procedure detects ferric iron (Fe 3+ ) which is the stable state of iron in most of its biological complexes (including when it is bound to Tf). Hb, however, utilizes ferrous iron so Prussian blue staining ought not detect iron in Hb. Ferric iron was detected both in control and Htt-deficient blood cells, and staining did not appear to be decreased in Htt-deficient cells ( Fig. 4G and H ). Since erythrocytes acquire iron for Hb exclusively via TfR-mediated endocytosis of Tf (61), this placed the disruption of Hb production downstream of TfR-mediated endocytosis of iron in the Httdeficient blood cells. This is consistent with the previous finding that Htt is not required for the endocytosis of TfR and Tf (65) .
Rescue of hypochromia and thin yolk extension phenotypes by provision of iron to the cytoplasm Following the detection of iron within the blood cells of Htt-deficient embryos, it was hypothesised that Htt may be required for rendering this intracellular iron available for cellular use (perhaps by facilitating iron release from the endocytic compartment). If this were the case, then provision of bio-available iron to the cytoplasm ought to bypass the need for Htt, and thereby rescue the hypochromic phenotype of Htt-deficient embryos.
A 'targeted rescue' experiment was therefore performed, based on a technique used to rescue the hypochromic phenotype of chianti genetic mutant zebrafish (61) . In zebrafish, gene duplication has given rise to two isoforms of TfR1: an erythroid specific isoform encoded by tfr1a
and a ubiquitously expressed isoform encoded by tfr1b. In chianti mutants, hypochromia is caused by a mutation in the blood specific tfr1a gene resulting in the inability of blood cells to absorb iron (as Tf) from the plasma (61). Hb production is restored in these embryos by injection of irondextran into the cytoplasm at the 1-cell stage such that all cells of the developing chianti embryos contain bio-available iron in the cytoplasm, hence circumventing the need for trf1a function (61).
To test whether provision of bio-available iron to the cytoplasm would restore Hb production in Htt-deficient embryos, iron-dextran was co-injected with hdMO1 (8.5 ng) at the 1-cell stage. Uninjected control embryos, hdMO-injected embryos, and embryos co-injected with hdMO1 and 100 ng iron-dextran were stained with o-dianisidine at 33 hpf ( Similar results were achieved in a second rescue experiment (Fig. 5 .6 G, Experiment 2), this time using greater population numbers, and using mcMO1-injected embryos as the control group.
The MO dose was the same as the previous experiment (8.5 ng), however the dose of iron-dextran used for the rescue was halved (50 ng). All control embryos (mcMO1-injected) had a normal YE and robust Hb staining (n = 47/47). The number of embryos with normal Hb levels was reduced to 20% (n = 10/49) in hdMO1-injected embryos, and co-injection of iron-dextran rescued to 66% (n = 29/44). Only 6% of hdMO1-injected embryos had a normal YE (n = 3/49), and iron supplementation was able to increase the number of embryos with a normal YE to 48% in the rescue group (n = 21/44). The ability of the addition of cytoplasmic iron to restore Hb production and rescue the thin yolk extension phenotype support the hypothesis that Htt knockdown causes cellular iron deficiency.
Morpholino effectiveness is not diminished by iron-dextran treatment
To ensure that iron-dextran did not decrease hdMO1 function, the hd(1. 
Htt-deficiency leads to an increase in TfR1 mRNAs
The results presented so far suggest that although iron is detected within the blood cells of Htt-deficient embryos, insufficient iron is available for cellular use, hence the decrease in Hb production. To further validate this model, quantitative real-time PCR (qPCR) methodology was used to examine the levels of TfR1 mRNA transcripts in Htt-deficient and control embryos. Since cells typically respond to iron starvation by up-regulating expression of TfR1 (69), it was predicted that levels of TfR1 mRNAs would be increased in Htt-deficient embryos. Levels of transcripts from both zebrafish paralogues of the TfR1 gene, tfr1a (erythroid specific) and tfr1b (ubiquitous) were each examined in embryos injected with 8.5 ng of hdMO1 or mcMO1 (mispair control MO), and wildtype uninjected control embryos, at 33 hpf. Levels of tfr1a and tfr1b transcripts were normalized to transcript levels of acta1 (Accession No. NM_131591), encoding actin alpha 1.
Normalized tfr1a and tfr1b triplicate values from three independent experiments are represented graphically in Figure 6 . One hdMO1/tfr1b value was considered to be an obvious outlier (indicated in Fig. 6B) , and was excluded from further statistical analyses. Provision of iron in a bio-available form to the cytoplasm restored haemoglobin production in Htt-deficient zebrafish embryos and also rescued the thin yolk extension phenotype. The thin yolk extension is a characteristic of previously described genetic mutant zebrafish lines that have defects in housekeeping genes, such as those encoding polymerases, ribosomal proteins, RNA processing factors and translation initiating factors (70) and is therefore likely to be a consequence of general cellular dysfunction. It is interesting to note however, that whilst genetic mutation of the erythroid specific tfr1a gene in chianti zebrafish results in hypochromic blood, morpholinomediated knockdown of the ubiquitous tfr1b isoform in zebrafish embryos causes phenotypes including thin yolk extension, small head and eyes, CNS necrosis and an overall morphology that is similar to Htt morphants, indicating that these phenotypes can result from cellular iron deficiency.
Further studies are required in order to elucidate the exact role of Htt in making iron accessible for cellular use. However, since erythroid cells acquire iron for Hb production solely by TfR-mediated endocytosis (61), a plausible explanation for intracellular iron not being available for
Hb production in Htt-deficient cells is that this iron has not been released from endocytic vesicles (Fig. 7) . It could therefore be envisioned that Htt might play a role in the targeting, transport, and/or fusion of iron-containing endocytic vesicles to acidic early endosomes for iron release into the 
How could perturbation of Htt function contribute to dominant, iron-related phenotypes in HD?
Various signs of disrupted iron homeostasis have been observed in HD patients. Levels of serum ferritin are decreased (83, 84) , which is a common indication of iron deficiency reflecting a reduction in body iron stores (85) . Also, reduced Hb levels have been observed in male HD patients (83) . The activities of many iron-requiring enzymes are decreased in HD patients, including aconitase and mitochondrial complexes I-IV, each of which plays a key role in oxidative energy production (86, 87) . Decreased activities of aconitase (19) and complexes II-IV (19-21) have been observed selectively in HD-affected brain regions, and decreased complex I activity has been recorded in muscle samples (88) . A number of studies have reported accumulation of iron specifically in the striatum of post-mortem HD brain samples (26, 28, 29) and a significant increase in ferritin iron has been detected in the striatum (and associated globus pallidus) of live HD patients, even in early symptomatic stages of disease (27, 89) .
How could a disruption of Htt's role in cellular iron utilization be connected to these dominant iron-related phenotypes in HD? HD does not appear to be caused by a simple loss of function of the affected allele (ie haploinsufficiency), since mice in which one Hdh allele is completely inactivated (Hdh +/-), and a human subject with a translocation interrupting one normal HD allele, do not develop HD symptoms (48, 49, 90) . Furthermore, HD patients who are homozygous for an expanded disease allele do not exhibit the embryonic lethality of Hdh knockout mice, but instead survive birth, and develop essentially as normal until the onset of symptoms (91, 92) . Therefore, in order for a disruption of Htt function to be responsible for the defects in iron homeostasis observed in HD, the expanded polyglutamine tract would have to alter Htt function in a manner that causes dominant, detrimental consequences in the Tf/TfR pathway. Whilst it is unclear whether the embryonic lethality of Hdh knockout (Hdh -/-) mice is solely attributable to disruption of cellular iron utilization, demonstrations that a single allele expressing expanded Htt is functionally sufficient to rescue Hdh -/-mice from embryonic lethality (51, 93, 94) , and the fact that HD is a lateonset disease, suggest that the polyglutamine expansion allows expanded Htt to retain at least some of its normal function, presumably including its role in cellular iron utilization.
In Further advancements in understanding of the sequence of events leading to pathology in these and other iron-related neurodegenerative disorders, may offer insight into HD pathology, and vice versa.
Conclusion
In this study, the zebrafish model organism has been used to examine the effects of Htt deficiency in early development, in order to gain new insight into the normal function of Htt. The most significant outcome of this work is the finding that Htt knockdown leads to signs of cellular iron deficiency despite the presence of iron in the cell. Htt appears to act downstream of TfRmediated endocytosis of iron, thus implicating Htt in the release of iron from endocytic compartments into the cytosol.
Iron is vital for the function of a variety of cellular proteins and enzymes, many of which play important roles in energy metabolism. Since defects in iron homeostasis (26-29, 83, 84, 89) and energy metabolism (reviewed in ref. (106)) are features of HD pathogenesis, the results of the current study raise the possibility that these defects are dominant effects of a perturbation (by the expanded polyglutamine tract) of Htt's normal role in the iron pathway. Furthermore, since iron accumulation and defects in energy metabolism are most pronounced in the primary site of HD neurodegeneration (19-21, 26-29, 89) , these findings provide a novel link between perturbation of normal Htt function, and the specificity of neuronal vulnerability in HD.
The hypothesis has been put forward that the normal function of Htt (and for that matter, each of the polyglutamine-containing disease proteins) is such that when perturbed this dysfunction contributes, in some way, to the specificity of the neurodegeneration seen in HD (and each of the other polyglutamine disorders). In order for this hypothesis to remain plausible the normal function(s) of Htt need to be consistent with some process that is able to account for such specificity of pathogenesis. We have found a clear role for Htt in cellular iron utilization -a process that is entirely consistent with the specificity of HD neurodegeneration in the striatum.
MATERIALS AND METHODS
Zebrafish maintenance and staging. Zebrafish were maintained at 28.5°C under standard conditions as described (107) . Developmental stages were determined by using both hours post fertilisation (hpf) and morphological features (108) .
Whole-mount in situ hybridization. The template used to make the probe for in situ hybridization of hd mRNA corresponds to the first 1503 bp of zebrafish hd open reading frame (ORF). This region was amplified from total cDNA from 72 hpf embryos using primers ZHD.F7+EcoRI (5'-CTGATGAATTCCATGGCCACCATGGAGAAGCTAA-3', start codon underlined) and ZHD.R7+XbaI (5'-GACTGTCTAGATGACATCTGGTTGGCATCGGTT-3'), and cloned into the eukaryotic expression vector pCS2+ (109) as an EcoRI/XbaI fragment. For synthesis of labeled antisense RNA probe, vector template was linearized at the 5' ClaI site and transcribed with T7
RNA polymerase in the presence of digoxigenin-labeled dUTP. notch2 (previously known as notch6) probe was prepared as described (110) . Whole-mount in situ hybridization was performed as described (111) . Proteinase K was used at a concentration of 10 μg/mL in PBST (0.1% Triton-X in PBS), to further permeabilize embryos aged 36 hpf (5 minutes) and 48 hpf (10 minutes).
Following hybridisation of the probe, alkaline phosphatase-conjugated anti-digoxigenin antibody and BCIP/NBT substrate were used for probe detection, as described (111) . Embryos were stored in 80% glycerol for microscopy and photography. Histochemical staining for haemoglobin. Hb activity was detected in whole embryos by performing o-dianisidine staining using methods previously described (112) . Finally embryos were rinsed 3 times in PBST, and stored in 80% glycerol for microscopy.
To obtain blood cells, live embryos (33 hpf) were placed in a solution of PBS, containing
tricaine. Blood cells were released by cardiac puncture onto a poly-L-lysine coated slide. Embryo debris was removed and blood cells were allowed to settle and adhere to the slide for 30 minutes.
The cells were then fixed in 4% formaldehyde (in PBS) for 30 minutes. Ferric iron was detected using a DAB-enhanced Prussian blue staining method similar to that used for whole embryos described above, with a few modifications, as follows. Cells were incubated in a working solution of 0.5% potassium ferrocyanide and 0.75% HCl (conditions previously described for staining blood cells (113) Following two rinses in PBST, embryos were incubated for 4 minutes in DAB substrate using PBSdissolved SigmaFast DAB/urea (H 2 O 2 ) tablets (Sigma-Aldrich). Finally, cells were rinsed 3 times in PBST, and air-dried before being covered with 80% glycerol and a coverslip for microscopy.
Quantitative PCR. Total RNA was extracted from zebrafish embryos (~ 30 embryos per sample) using the RNeasy mini kit (QIAGEN). From this RNA, cDNA was synthesized using Superscript II RNase H-Reverse Transcriptase (Invitrogen). Quantitative real-time PCR (qPCR) was performed on an ABI 7000 sequence detection system (Applied Biosciences), using the relative standard curve method for quantification (as set out by the manufacturers) to generate raw values representing arbitrary units of RNA transcript. The experiment was performed on three independent occasions.
In every experiment, each embryo sample was run in triplicate. Triplicate values for acta1 were averaged, and each triplicate tfr1a and tfr1b value was then normalised to the average acta1 value for that sample. One hdMO1/tfr1b value was omitted from statistical analyses as it was > 2.5 standard deviations from the mean value observed for that embryo class and was therefore considered an outlier. Statistical analyses on normalized data were performed using R software (114) and included ANOVA and Student's t tests. The following primers were used: tfr1a (fwd:
AATCGCATTATGAGGGTGGAA and rev: GGGAGACACGTATGGAGAGAGC); tfr1b (fwd:
AAGAATAGTGACCTGGAAGACATGG and rev: AATGAGACGTAAGGAGAGAGGAAATT);
and acta1 (fwd: TGCCCAGAGGCCCTGTT and rev: ACCGCAAGATTCCATACCCA). control embryos were uninjected; and 100 ng of iron-dextran was co-injected with hdMO1 in the rescue group. In Experiment 2, control embryos were injected with 8.5 ng of mcMO1, and 50 ng of iron-dextran was co-injected with hdMO1 in the rescue group.
LEGENDS TO FIGURES
FIGURE 6
Levels of tfr1a and tfr1b transcripts are increased in response to Htt knockdown. Quantitative PCR was used to compare the levels of tfr1a (A, C) and tfr1b (B, D) transcripts in zebrafish embryos injected with either mcMO1 or hdMO1, and uninjected embryos. Levels of tfr1a
and tfr1b transcripts were normalised to the level of acta1 transcript. Normalised triplicate values from three independent experiments are graphically represented for tfr1a transcript levels (A) and tfr1b transcript levels (B). A data point that was considered an outlier is indicated (B). In (C and D) the same data shown in (A and B) , excluding the outlier, is represented in box-plot format. The 
FIGURE 7
Schematic model illustrating how disruption of haemoglobin production in Htt-deficient zebrafish blood cells is rescued by provision of bio-available iron (iron-dextran) to the cytoplasm. In normal cells, binding of iron-loaded transferrin (Tf) to the transferrin receptor (TfR) on the plasma membrane initiates clathrin-mediated endocytosis of the receptor/ligand complex into endocytic vesicles that then lose their clathrin coat and fuse to early endosomes (ref. (115)). The decreased internal pH of the early endosome causes iron to disassociate from apo-Tf/TfR, facilitating its release into the cytoplasm via divalent metal transporter, DMT1 (ref (116) ). Once released iron enters the mitochondria where it is incorporated into haem (and iron-sulfur clusters).
In erythroid cells, most haem is utilised (in conjunction with globin) as haemoglobin (Hb).
When Htt levels are depleted by morpholino knockdown, the availability of iron endocytosed by the Tf/TfR pathway (for utilisation in Hb) is compromised. Supplementing the cytoplasm with bio-
